Close Menu

NEW YORK – A public-private partnership in Oklahoma is gearing up to begin high-throughput molecular diagnostic testing for COVID-19 using Fluidigm's microfluidic technology, the partners said on Thursday.

The real-time PCR test, developed by the nonprofit Oklahoma Medical Research Foundation and the University of Oklahoma Health Sciences Center, will run on Fluidigm's Biomark HD system and is intended for large-scale testing of patients across the OU Medicine healthcare system and, eventually, the entire state, stakeholders said in a webcast announcing the initiative on Thursday.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.

A study of Great Danes homes in on a genomic region linked to fearfulness.

CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.

In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.